Stocks
Integra LifeSciences Holdings Corporation (IART) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 13.6% | 14.1% | 15.6% | 17.8% | 19.3% | 11.7% | ||
| Changes by years, y/y, % | +4pp | +0pp | +2pp | +2pp | +2pp | +14.7% | |||
Integra LifeSciences Holdings Corporation. EBITDA margin, %
Integra LifeSciences Holdings Corporation. EBITDA margin, changes, pp
Integra LifeSciences Holdings Corporation (IART) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | 11.8% | 5.07% | 9.12% | 21.8% | 10.6% | 11.7% | |
| Changes by years, y/y, % | -10pp | -18pp | -17pp | +1pp | -1pp | |||
| Changes by quarters, q/q, % | -8pp | -7pp | +4pp | +13pp | -11pp | |||
